IRCT20190525043700N1
Completed
未知
Comparative Effect of Citalopram and Escitalopram in the Management of Depressive Symptoms among Patients with Schizophrenia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Babol University of Medical Sciences
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of schizophrenia based on DSM\-IV TR structured clinical interview by a psychiatrist (faculty member and psychiatry resident)
- •Diagnosis of depression based on DSM\-IV TR structured clinical interview by a psychiatrist (faculty member and psychiatry resident)
Exclusion Criteria
- •Ischemia Heart Disease
- •Heart Failure
- •Mental retardation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
Active, not recruiting
Not Applicable
Escitalopram versus Citalopram Treatment effects on cortical and subcortical activity assessed by pharmacological fMRIHealthy volunteersEUCTR2005-002701-23-ATSiegfried Kasper, O.Univ.Prof.Dr.Dr.h.c.18
Completed
Phase 2
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
Completed
Phase 2
Effect of Olanzapine and Aripiprazole in schizophrenic patientsSchizophrenia.SchizophreniaIRCT2013090714577N1Research deputy of Ardabil University of Medical Science80
Recruiting
Phase 2
A comparative study of the effect of citalopram in the prevention of delirium in intubated patients without brain damage in Labafinejad Hospital ICIRCT20190215042716N6Shahid Beheshti University of Medical Sciences62